Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1037.3000 -10.55 (-1.01%)
NSE Sep 19, 2025 15:31 PM
Volume: 1.1M
 

logo
Zydus Lifesciences Ltd.
21 Nov 2019
1037.30
-1.01%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Geojit BNP Paribas increased Buy price target of Zydus Lifesciences Ltd. to 1121.0 on 03 Sep, 2025.
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - September 19, 2025
The Baseline | 19 Sep 2025, 04:31PM
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch | 19 Sep 2025, 03:58PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020